NCT04309890已完成不适用
Validating 7-items Overactive Bladder Symptom Score (OABSS) Through Arabic Linguistic Version
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 235
- 试验地点
- 1
- 主要终点
- development and validation of Arabic version of the Overactive Bladder Symptom Score (OABSS) questionnaire
研究概览
简要总结
The English version of the Overactive Bladder Symptom Score (OABSS) questionnaire was translated to Arabic language. The questionnaire was validated by comparing the response to the questionnaire in a patient with Overactive Bladder (OAB) before and after providing treatment with antimuscarinics.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •More than 20 years
- •Had three months history of overactive bladder symptoms (urgency with or without incontinence and associated with frequency and nocturia).
排除标准
- •Active urinary tract infection.
- •Predominant symptoms of urinary stress incontinence;
- •Diabetes mellitus;
- •Previous abdominal and pelvic (urological or gynecological gastrointestinal) surgery;
- •Previous neurological disease.
结局指标
主要结局
development and validation of Arabic version of the Overactive Bladder Symptom Score (OABSS) questionnaire
时间窗: 3 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Reproducibility Study of OABSS and Its Response to TreatmentOveractive BladderNCT02667470Astellas Pharma Inc50
已完成
不适用
Reliability of Polish-Version Overactive Bladder Syndrom Scores (OABSS)Urinary IncontinenceOveractive BladderNCT03801239Medical University of Lublin822
已完成
不适用
Reproducibility Study of Over Active Bladder Symptom Score [OABSS]Overactive BladderNCT00901251Astellas Pharma Inc50
已完成
4 期
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin TreatmentOver Active BladderNCT01318837Astellas Pharma Inc100
已完成
不适用
Reproducibility Study of Overactive Bladder Symptom Score [OABSS]Overactive BladderNCT01122550Astellas Pharma Inc50